Moderna Financials
| 0QF Stock | EUR 40.49 0.99 2.51% |
Moderna |
Understanding current and past Moderna Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Moderna's financial statements are interrelated, with each one affecting the others. For example, an increase in Moderna's assets may result in an increase in income on the income statement.
Moderna Stock Summary
Moderna competes with BioNTech, Novavax, and CureVac NV. Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1800 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US60770K1079 |
| Business Address | 200 Technology Square, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.modernatx.com |
| Phone | 617 714 6500 |
| Currency | EUR - Euro |
You should never invest in Moderna without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Moderna Stock, because this is throwing your money away. Analyzing the key information contained in Moderna's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Moderna Key Financial Ratios
There are many critical financial ratios that Moderna's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Moderna reports annually and quarterly.| Return On Equity | 0.5 | |||
| Return On Asset | 0.23 | |||
| Beta | 1.64 | |||
| Z Score | 49.8 |
Moderna Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Moderna's current stock value. Our valuation model uses many indicators to compare Moderna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Moderna competition to find correlations between indicators driving Moderna's intrinsic value. More Info.Moderna is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Moderna is roughly 2.16 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Moderna's earnings, one of the primary drivers of an investment's value.Moderna Systematic Risk
Moderna's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Moderna volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Moderna correlated with the market. If Beta is less than 0 Moderna generally moves in the opposite direction as compared to the market. If Moderna Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Moderna is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Moderna is generally in the same direction as the market. If Beta > 1 Moderna moves generally in the same direction as, but more than the movement of the benchmark.
Moderna January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Moderna help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Moderna. We use our internally-developed statistical techniques to arrive at the intrinsic value of Moderna based on widely used predictive technical indicators. In general, we focus on analyzing Moderna Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Moderna's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 28.12 | |||
| Value At Risk | (8.86) | |||
| Potential Upside | 8.75 |
Complementary Tools for Moderna Stock analysis
When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |